Analysis of Benzenoid Substitution Patterns in Small Molecule Active Pharmaceutical Ingredients
- 13 August 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (22), 13389-13396
- https://doi.org/10.1021/acs.jmedchem.0c00915
Abstract
Previous analyses have revealed that benzenoid rings are prevalent scaffolds in active pharmaceutical ingredients (APIs). Here, we analyze the substitution patterns of benzenoid rings in small molecule APIs approved by the FDA through 2019 and show that only a few substitution patterns (1-; 1,2-; 1,4-; and 1,2,4-) prevail, and the distribution has remained relatively constant over time. We postulate the connection between available synthetic methods and the occurrence of a few benzenoid substitution patterns by providing an overview of synthetic methods that elaborate existing substitution patterns and those that create new substitution patterns, including those of the former that are favored by medicinal chemists. Finally, we calculated medicinal chemistry properties of benzenoid containing APIs that are often used by practitioners as design elements, including “druglikeness”, shape, complexity, and similarity/diversity and discuss these properties in the context of synthesis.Keywords
Other Versions
Funding Information
- Portland State University
This publication has 57 references indexed in Scilit:
- Analysis of Benzenoid Substitution Patterns in Small Molecule Active Pharmaceutical IngredientsPublished by American Chemical Society (ACS) ,2019
- Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug DesignJournal of Medicinal Chemistry, 2018
- Beyond C, H, O, and N! Analysis of the Elemental Composition of U.S. FDA Approved Drug ArchitecturesJournal of Medicinal Chemistry, 2014
- Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and DiscoveryJournal of Medicinal Chemistry, 2013
- The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?Drug Discovery Today, 2009
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical SuccessJournal of Medicinal Chemistry, 2009
- Quest for the Rings. In Silico Exploration of Ring Universe To Identify Novel Bioactive Heteroaromatic ScaffoldsJournal of Medicinal Chemistry, 2006
- Drug Rings Database with Web Interface. A Tool for Identifying Alternative Chemical Rings in Lead Discovery ProgramsJournal of Medicinal Chemistry, 2003
- Principal Components Describing Biological Activities and Molecular Diversity of Heterocyclic Aromatic Ring FragmentsJournal of Medicinal Chemistry, 1996
- The Properties of Known Drugs. 1. Molecular FrameworksJournal of Medicinal Chemistry, 1996